Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients
Table 1
Demographic and clinical characteristics of patients with recurrent angioedema (RAE) (n = 86) as well as their response to treatment and disease activity, as assessed by the Thai Angioedema Activity Score 28 (AAS28) and Patient Global Assessment of Disease Activity (PGA-DA).
Values
Gender, n (%)
Female
69 (80.2)
Male
17 (19.8)
Age, years
Mean age (range)
38 ± 15 (18–76)
Diagnosis, n (%)
RAE without wheals
10 (11.6)
RAE with wheals
76 (88.0)
Range of scores (full score)
Thai AAS28
0–228 (420)
PGA-DA
0–3 (4)
Mean scores ± SD
Thai AAS28
22.0 ± 42.5
PGA-DA
1.1 ± 1.0
Treatment, n (%)
H1-antihistamines
74 (86)
H1-antihistamines + prednisolone
8 (9)
H1-antihistamines + omalizumab
4 (5)
Assessment of disease activity using the PGA-DA questionnaire, n (%)
